Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N W J Bulkmans

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
British Journal of Cancer|April 14, 2005
Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screeningN W J Bulkmans, L Rozendaal, F J Voorhorst, et al.
British Journal of Cancer|January 10, 2008
Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screeningV M H Coupé, J Berkhof, N W J Bulkmans, et al.
Journal of Clinical Microbiology|October 6, 2006
Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening programA T Hesselink, N W J Bulkmans, J Berkhof, et al.
British Journal of Cancer|January 13, 2006
Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The NetherlandsS Bulk, J Berkhof, N W J Bulkmans, et al.
British Journal of Cancer|March 8, 2007
High-risk HPV type-specific clearance rates in cervical screeningN W J Bulkmans, J Berkhof, S Bulk, et al.
Journal of Clinical Pathology|September 1, 2006
Implementation of human papillomavirus testing in cervical screening without a concomitant decrease in participation rateN W J Bulkmans, S Bulk, M S Ottevanger, et al.
Lancet (London, England)|October 9, 2007
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trialN W J Bulkmans, J Berkhof, L Rozendaal, et al.
ESMO Open|April 13, 2024
Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor-stroma ratio in colon cancerM Polack, M A Smit, G W van Pelt, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
British Journal of Cancer|April 14, 2005
Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screeningN W J Bulkmans, L Rozendaal, F J Voorhorst, et al.
British Journal of Cancer|January 10, 2008
Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screeningV M H Coupé, J Berkhof, N W J Bulkmans, et al.
Journal of Clinical Microbiology|October 6, 2006
Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening programA T Hesselink, N W J Bulkmans, J Berkhof, et al.
British Journal of Cancer|January 13, 2006
Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The NetherlandsS Bulk, J Berkhof, N W J Bulkmans, et al.
British Journal of Cancer|March 8, 2007
High-risk HPV type-specific clearance rates in cervical screeningN W J Bulkmans, J Berkhof, S Bulk, et al.
Journal of Clinical Pathology|September 1, 2006
Implementation of human papillomavirus testing in cervical screening without a concomitant decrease in participation rateN W J Bulkmans, S Bulk, M S Ottevanger, et al.
Lancet (London, England)|October 9, 2007
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trialN W J Bulkmans, J Berkhof, L Rozendaal, et al.
ESMO Open|April 13, 2024
Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor-stroma ratio in colon cancerM Polack, M A Smit, G W van Pelt, et al.
Pageof 1